Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

663
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
663
Vaccinations01:51

Vaccinations

49.2K
Overview
49.2K
Cross-reactivity00:42

Cross-reactivity

32.1K
Overview
32.1K
Cancer Vaccines01:30

Cancer Vaccines

624
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
624

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: How social relationships shape moral wrongness judgments.

Nature communications·2024
Same author

Seasonal variation in SARS-CoV-2 transmission in temperate climates: A Bayesian modelling study in 143 European regions.

PLoS computational biology·2022
Same author

Insidious Insights: Implications of viral vector engineering for pathogen enhancement.

Gene therapy·2022
Same author

Author Correction: How social relationships shape moral wrongness judgments.

Nature communications·2021
Same author

Rapid Proliferation of Pandemic Research: Implications for Dual-Use Risks.

mBio·2021
Same author

Understanding the effectiveness of government interventions against the resurgence of COVID-19 in Europe.

Nature communications·2021
Same journal

Modeling time-varying efficacy of RTS,S/AS01 malaria vaccine across trial settings.

NPJ vaccines·2026
Same journal

EGFR mimotope alleviates renal fibrosis by promoting EGFR/RPL6/PCBP2 ternary complex formation.

NPJ vaccines·2026
Same journal

Epitope-selective vaccine designs to elicit protective antibodies against the Plasmodium falciparum circumsporozoite protein.

NPJ vaccines·2026
Same journal

Oral contraceptive usage among healthcare workers and its impact on COVID-19 booster vaccination immunogenicity.

NPJ vaccines·2026
Same journal

Mapping SARS-CoV-2 immunity after an XBB.1.5 booster by antigenic cartography of merged human and hamster sera.

NPJ vaccines·2026
Same journal

Safety and immunogenicity of concomitant quadrivalent meningococcus ACYW-TT and meningococcus group B vaccines.

NPJ vaccines·2026
See all related articles

Related Experiment Video

Updated: Nov 17, 2025

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.6K

Promoting versatile vaccine development for emerging pandemics.

Joshua T Monrad1,2,3, Jonas B Sandbrink4,5, Neil G Cherian6,7

  • 1Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK. joshua.monrad@gmail.com.

NPJ Vaccines
|February 12, 2021
PubMed
Summary
This summary is machine-generated.

Flexible vaccine platforms and prototype pathogen research are crucial for pandemic preparedness. Proactive investment in versatile vaccine technologies accelerates development and enhances global health security against emerging infectious diseases.

More Related Videos

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.8K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.4K

Related Experiment Videos

Last Updated: Nov 17, 2025

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.6K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.8K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.4K

Area of Science:

  • Vaccinology
  • Infectious Disease Research
  • Biomedical R&D Financing

Background:

  • The COVID-19 pandemic highlighted the need for rapid development of medical countermeasures like vaccines.
  • Existing pathogen-specific funding models may not adequately support research and development (R&D) for emerging pandemic threats.
  • Versatile vaccine platforms and prototype pathogen research are key to improving pandemic preparedness.

Purpose of the Study:

  • To discuss the role of platform vaccines and prototype pathogen research in modern vaccine development.
  • To outline improvements for pathogen-specific funding approaches to better promote vaccine R&D for emerging pandemics.
  • To present a comprehensive financing approach for vaccine R&D that maximizes biomedical pandemic preparedness.

Main Methods:

  • Discussion of the strategic importance of flexible vaccine platforms.
  • Analysis of prototype pathogen research for translatable vaccine development.
  • Proposal for a revised funding strategy for vaccine R&D.

Main Results:

  • Platform-based vaccines (e.g., for SARS-CoV-2) demonstrate the potential for accelerated pandemic response.
  • Proactive investment in versatile platform technologies by funders can significantly speed up vaccine development.
  • A comprehensive financing approach should consider the full social value of enhanced preparedness for emerging infectious diseases.

Conclusions:

  • Investing in flexible vaccine platforms and translatable research is essential for maximizing biomedical pandemic preparedness.
  • Funding decisions for vaccine R&D should account for the broader societal benefit of preparedness against multiple potential pandemic pathogens.
  • A shift from pathogen-specific funding to platform-centric investment strategies is recommended for future pandemic response.